Risk for stroke or systemic embolism lower with apixaban versus aspirin for patients with subclinical a-fib

Liberal transfusion strategy does not significantly reduce the risk for recurrent myocardial infarction or death

Findings seen over three years in adults with preexisting cardiovascular disease and overweight or obesity

Findings seen among low-income individuals with diabetes and poor glycemic control

Compared with mid and high SES, low SES was linked to increased absolute risk of 5.4 and 10.1 percent

And, cannabis use disorder linked to increased odds of major adverse cardiac and cerebrovascular events

Incidence of atrioventricular block increased with higher antibody levels, reaching 7.7 percent in top quartile of anti-60 kD SSA-Ro

Leading contributors to widening gender life expectancy gap from 2019 to 2021 included COVID-19, unintentional injuries

PREVENT equations developed and validated in adults aged 30 to 79 years without known CVD and included eGFR as a predictor

Younger age at a-fib onset linked to increased risks of all-cause and vascular dementia, Alzheimer disease